Identification of monotonically differentially expressed genes for non-small cell lung cancer

被引:11
作者
Tian, Suyan [1 ]
机构
[1] Jilin Univ, Div Clin Res, Hosp 1, 71 Xinmin St, Changchun 130021, Jilin, Peoples R China
基金
中国国家自然科学基金;
关键词
Non-small cell lung cancer (NSCLC); Monotonically expressed genes (MEGs); Pathologic stages; Overall survival; Feature selection; Adenocarcinoma; Squamous cell carcinoma; EARLY-STAGE; SIGNATURE; PREDICTION;
D O I
10.1186/s12859-019-2775-8
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Monotonically expressed genes (MEGs) are genes whose expression values increase or decrease monotonically as a disease advances or time proceeds. Non-small cell lung cancer (NSCLC) is a multistage progression process resulting from genetic sequences mutations, the identification of MEGs for NSCLC is important. Results: With the aid of a feature selection algorithm capable of identifying MEGs - the MFSelector method - two sets of potential MEGs were selected in this study: the MEGs across the different pathologic stages and the MEGs across the risk levels of death for the NSCLC patients at early stages. For the lung adenocarcinoma (AC) subtypes no statistically significant MEGs were identified across pathologic stages, however dozens of MEGs were identified across the risk levels of death. By contrast, for the squamous cell lung carcinoma (SCC) there were no statistically significant MEGs as either stage or risk level advanced. Conclusions: The pathologic stage of non-small cell lung cancer patients at early stages has no prognostic value, making the identification of prognostic gene signatures for them more meaningful and highly desirable.
引用
收藏
页数:9
相关论文
共 23 条
[1]  
[Anonymous], SCI REPORTS
[2]  
[Anonymous], 2018, ANTI-CANCER DRUG, DOI [DOI 10.3322/caac.20115, DOI 10.1097/CAD.0000000000000617]
[3]   Biomarker Discovery in Non-Small Cell Lung Cancer: Integrating Gene Expression Profiling, Meta-analysis, and Tissue Microarray Validation [J].
Botling, Johan ;
Edlund, Karolina ;
Lohr, Miriam ;
Hellwig, Birte ;
Holmberg, Lars ;
Lambe, Mats ;
Berglund, Anders ;
Ekman, Simon ;
Bergqvist, Michael ;
Ponten, Fredrik ;
Koenig, Andre ;
Fernandes, Oswaldo ;
Karlsson, Mats ;
Helenius, Gisela ;
Karlsson, Christina ;
Rahnenfuehrer, Joerg ;
Hengstler, Jan G. ;
Micke, Patrick .
CLINICAL CANCER RESEARCH, 2013, 19 (01) :194-204
[4]   Validation of a Histology-Independent Prognostic Gene Signature for Early-Stage, Non-Small-Cell Lung Cancer Including Stage IA Patients [J].
Der, Sandy D. ;
Sykes, Jenna ;
Pintilie, Melania ;
Zhu, Chang-Qi ;
Strumpf, Dan ;
Liu, Ni ;
Jurisica, Igor ;
Shepherd, Frances A. ;
Tsao, Ming-Sound .
JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (01) :59-64
[5]   STRING v9.1: protein-protein interaction networks, with increased coverage and integration [J].
Franceschini, Andrea ;
Szklarczyk, Damian ;
Frankild, Sune ;
Kuhn, Michael ;
Simonovic, Milan ;
Roth, Alexander ;
Lin, Jianyi ;
Minguez, Pablo ;
Bork, Peer ;
von Mering, Christian ;
Jensen, Lars J. .
NUCLEIC ACIDS RESEARCH, 2013, 41 (D1) :D808-D815
[6]   Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction [J].
Hou, Jun ;
Aerts, Joachim ;
den Hamer, Bianca ;
van IJcken, Wilfred ;
den Bakker, Michael ;
Riegman, Peter ;
van der Leest, Cor ;
van der Spek, Peter ;
Foekens, John A. ;
Hoogsteden, Henk C. ;
Grosveld, Frank ;
Philipsen, Sjaak .
PLOS ONE, 2010, 5 (04)
[7]   Adjusting batch effects in microarray expression data using empirical Bayes methods [J].
Johnson, W. Evan ;
Li, Cheng ;
Rabinovic, Ariel .
BIOSTATISTICS, 2007, 8 (01) :118-127
[8]   KRAS Mutations in Lung Cancer [J].
Karachaliou, Niki ;
Mayo, Clara ;
Costa, Carlota ;
Magri, Ignacio ;
Gimenez-Capitan, Ana ;
Angel Molina-Vila, Miguel ;
Rosell, Rafael .
CLINICAL LUNG CANCER, 2013, 14 (03) :205-214
[9]   A robust prognostic gene expression signature for early stage lung adenocarcinoma [J].
Krzystanek M. ;
Moldvay J. ;
Szüts D. ;
Szallasi Z. ;
Eklund A.C. .
Biomarker Research, 4 (1)
[10]  
Liu W, 2014, AM J CANCER RES, V4, P256